Palo Alto, CA, United States of America

Esther Yesde Son


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Esther Yesde Son: Innovator in Motor Neuron Research

Introduction

Esther Yesde Son is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of neuroscience, particularly in the area of motor neuron research. Her innovative work focuses on the conversion of somatic cells into functional spinal motor neurons, which has important implications for treating motor neuron diseases.

Latest Patents

Esther Yesde Son holds a patent for the "Conversion of somatic cells into functional spinal motor neurons, and methods and uses thereof." This invention provides methods for the transdifferentiation of somatic cells, such as fibroblasts, into induced motor neurons (iMNs). The patent outlines a process that increases the protein expression of specific motor-neuron inducing factors, enabling the conversion of fibroblasts into iMNs that exhibit characteristics of typical motor neurons. This groundbreaking work has potential applications in the treatment of diseases like ALS and SMA.

Career Highlights

Throughout her career, Esther has worked with prestigious institutions, including Harvard College and Children's Medical Center Corporation. Her research has garnered attention for its innovative approach to addressing critical challenges in motor neuron diseases.

Collaborations

Esther has collaborated with notable researchers in her field, including Kevin Carl Eggan and Clifford J Woolf. These partnerships have further advanced her research and contributed to the development of effective treatments for motor neuron diseases.

Conclusion

Esther Yesde Son's contributions to the field of neuroscience through her innovative patent and collaborative efforts highlight her role as a leading inventor in motor neuron research. Her work continues to pave the way for advancements in the treatment of debilitating motor neuron diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…